Top-Tier Biopharma Benefits from Baker Brand Therapy
Cephalon Launches Strong and Healthy Brand After Partnering with Baker
Santa Monica, CA — Baker has completed brand development and launch of a fully integrated communications program designed to take the corporate brand at Cephalon, Inc. (Nasdaq: CEPH) to the next level. Already one of the world’s fastest growing pharmaceutical companies, Pennsylvania-based Cephalon has rapidly achieved a broad international presence and earned distinction for its proprietary products for the treatment of neurological diseases, sleep disorders, cancer and pain.
According to Gary Baker, founder and president of Baker, “This has been an exciting assignment for our whole team here at Baker. A program of this scope touches virtually every facet of our operation including research, strategy, messaging, design, production and certainly client services. Cephalon is the world’s fifth largest biotech company and we’re proud to be their go-to resource for articulating their story and tailoring it to all the audiences they need to reach.”
A key differentiator at Cephalon is its heritage in the biopharmaceutical sector as the groundbreaking innovator of a balanced risk business model. “Baker stepped in at a critical time in the development of our company and we have been continually impressed by their ability to get to the heart of our positioning in a fresh and intelligent way.” explains Robert Grupp, Vice President of Corporate Communications at Cephalon. “We are an entrepreneurial organization that is breaking new ground in the way drugs are developed. With similar qualities and energy, Baker proved to be an excellent fit as our corporate branding partner.”
Among the first deliverables of the Cephalon brand launch is a complete brand strategy platform, a visual identity refresh, a new corporate website, the 2003 Annual Report and a brand brochure, video and posters. Other applications under development as part of the 2004 brand communications plan include an ad for publication in Forbes magazine, the creation of branded environments at the company’s various offices and a comprehensive online brand guidelines resource documenting virtually all types of communications at Cephalon.
About Cephalon
Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat sleep and neurological disorders, cancer and pain. Cephalon currently employs approximately 1,600 people in the United States and Europe. U.S. sites include the company’s headquarters in West Chester, Pennsylvania, and offices and manufacturing facilities in Salt Lake City, Utah. Cephalon’s major European offices are located in Guildford, England, Martinsried, Germany, and Maisons-Alfort, France. The company currently markets three proprietary products in the United States: PROVIGIL, GABITRIL, ACTIQ and more than 20 products internationally. Full prescribing information on its U.S. products is available at www.cephalon.com.
About Baker | Brand Communications
Baker is a corporate brand consultancy and communications design firm. For nearly 25 years we’ve been helping corporations achieve their business objectives and market potential through strategically grounded, creatively driven communications. Baker’s award-winning strategists, writers, designers and dedicated account teams draw upon proven methodologies and offer clients a superior level of service. Our comprehensive communications services include brand strategy and development, identity systems and naming, corporate communications, annual reports, marketing communications, interactive, video/media and brand management.
Gary Baker
President & Executive Creative Director
800.939.5008 x308
g.baker@bakerbrand.com